loadpatents
name:-0.0012311935424805
name:-0.0040848255157471
name:-0.00096011161804199
Baulard; Alain Patent Filings

Baulard; Alain

Patent Applications and Registrations

Patent applications and USPTO patent grants for Baulard; Alain.The latest application filed is for "spiroisoxazoline compounds having an activity potentiating the activity of an antibiotic".

Company Profile
1.7.4
  • Baulard; Alain - Tournai BE
  • Baulard; Alain - Templeuve BE
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Spiroisoxazoline compounds having an activity potentiating the activity of an antibiotic
Grant 10,174,050 - Willand , et al. J
2019-01-08
Saturated nitrogen and N-acylated heterocycles potentiating the activity of an active antibiotic against Mycobacteria
Grant 9,957,249 - Willand , et al. May 1, 2
2018-05-01
Compounds for use in the treatment of mycobacterial infections
Grant 9,920,042 - Willand , et al. March 20, 2
2018-03-20
Spiroisoxazoline Compounds Having an Activity Potentiating the Activity of an Antibiotic
App 20150344498 - Willand; Nicolas ;   et al.
2015-12-03
Saturated Nitrogen and N-Acylated Heterocycles Potentiating the Activity of an Active Antibiotic against Mycobacteria
App 20150307471 - Willand; Nicolas ;   et al.
2015-10-29
Compounds For Use In The Treatment Of Mycobacterial Infections
App 20150225388 - Willand; Nicolas ;   et al.
2015-08-13
Fluoralkylcarbonyl-oxadiazoles
Grant 8,962,658 - Deprez , et al. February 24, 2
2015-02-24
Fluoralkylcarbonyl-oxadiazoles
App 20140309238 - Deprez; Benoit ;   et al.
2014-10-16
Compounds having a potentiating effect on the activity of ethionamide and uses thereof
Grant 8,338,599 - Deprez , et al. December 25, 2
2012-12-25
Shuttle vectors for the introduction of DNA into mycobacteria and utilization of such bacteria as vaccines
Grant 6,472,213 - Escuyer , et al. October 29, 2
2002-10-29
Shuttle vectors for the introduction of DNA into mycobacteria and utilization of such bacteria as vaccines
Grant 6,074,866 - Escuyer , et al. June 13, 2
2000-06-13

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed